Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicle biology advancements may lead to better hair growth disorder treatments.

Lysophosphatidic acid is important for skin health and disease, and could be a target for new skin disorder treatments.

The composition with carnitine, thioctic acid, and saw palmetto extract may effectively reduce inflammation in hair follicle cells.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

The document concludes that understanding hair follicle biology can lead to better hair loss treatments.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

Hair follicles are hormone-sensitive and involved in growth and other functions, with potential for new treatments, but more research is needed.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

The research found how GPCR Class A Rhodopsin receptors are related and suggested possible substances they interact with.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Hair follicles on the scalp interact with and respond to the nervous system, influencing their own behavior and growth.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

Adding antihistamines to topical corticosteroid and cryotherapy may improve hair regrowth in alopecia areata patients.

Treating both the mind and skin together, especially by managing stress, can greatly improve outcomes for skin disorders linked to psychological issues.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

The document concludes that the skin is a complex organ providing protection, sensation, and healing, with challenges in treating conditions like itchiness.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

Female rats showed more panic-related behavior than males, influenced by hormonal cycles and certain drugs.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

The symposium highlighted the skin's role in sensing itch, pain, touch, and pleasure, and discussed new research and techniques for understanding and treating these sensations.

DHEA affects multiple receptors and may help with metabolic issues, but its safety and effectiveness in humans are unclear.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

Certain brain hormones and chemicals are linked to the development of Polycystic Ovary Syndrome.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Stress hormones and autoimmune reactions can cause hair loss.

Botulinum toxin is effective for various skin conditions, but more research and awareness of side effects are needed.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.